China · Investor

Kaitai Capital

Last cheque observed Aug 2026; 76 cheques on record.

Deploying nowVC firm

SeedSeries ASeries BArtificial IntelligenceBiotechLife Sciences

Deploying now
57%of best year8cheques in 12 months, 76 on record
Since the last cheque86days00hrs00min00sec
Median round$14MRounds led0 of 76Sole investor30 roundsMostly inUnited States, 83%
Pitch Kaitai Capital

Kaitai Capital highlights

  1. 01

    8 cheques in the last 12 months

  2. 02

    Mostly Series A and Venture: 54% of its rounds

  3. 03

    Sole investor in 30 rounds, median $3.0M

What they do

Kaitai Capital is a venture capital management institution, primarily engaged in innovative investment management business.Translated from Chinese, from their own website
Type
VC firm
Cheque size
Not stated
Stages
SeedSeries ASeries B
Sectors
Artificial IntelligenceBiotechLife Sciences
Based in
Hangzhou, China
Cold pitches
Accepted

The record

Every round we can evidence, newest first76 appearances

  1. 2026

    5 rounds

  2. Aug
    Astrocyte PharmaceuticalsGrant · US$400KWith 2 others
  3. Mar
    Deep Intelligent PharmaVenture · SG$40MWith 3 others
  4. Mar
    PaXini TechSeries B$145MWith 1 other
  5. Feb
    West Lake XinchenSeed$15MWith 2 others
  6. Jan
    Xihu XinchenVentureUndisclosedWith 2 others
  7. 2025

    12 rounds

  8. Dec
    Worg PharmaceuticalsSeries D$43MWith 2 others
  9. Dec
    LevinthalVentureUndisclosedWith 1 other
  10. Nov
    Junsai ShengwuSeries C$19MWith 1 other
  11. Oct
    OncoC4Series B · US$50MWith 1 other
  12. Oct
    BridGene BiosciencesSeries B · US$28MSole investor
  13. Sept
    Youxin Cloud$6.0MWith 2 others
  14. Aug
    Huaboron NeutronVentureUndisclosedWith 1 other
  15. Aug
    Pleryon TherapeuticsVentureUndisclosedSole investor
  16. Aug
    Minova PharmaSeries B$14MWith 2 others
  17. Jul
    Xinbele BioVentureUndisclosedSole investor
  18. Mar
    Chance PharmaceuticalsVentureUndisclosedWith 1 other
  19. Jan
    BivisionSeries A$14MWith 2 others
  20. 2024

    4 rounds

  21. Dec
    Ruixun BiotechVentureUndisclosedWith 1 other
  22. May
    XinyueSeries A$1.4MWith 3 others
  23. Jan
    TechnoDerma MedicinesVentureUndisclosedWith 1 other
  24. Jan
    Phanes TherapeuticsVenture · USUndisclosedWith 2 others
  25. 2023

    8 rounds

  26. Dec
    Ceram PharmaceuticalsSeries A$14MWith 2 others
  27. Oct
    Atom Bioscience & PharmaceuticalSeries D$82MWith 3 others
  28. Sept
    Nafi PharmaceuticalsVentureUndisclosedSole investor
  29. Aug
    Circular Code BiologyVentureUndisclosedWith 1 other
  30. Aug
    Astrocyte PharmaceuticalsSeries B · US · Firms' own news pages$6.0MWith 10 others
  31. Aug
    CirCodeVentureUndisclosedWith 1 other
  32. May
    Hongyun BiotechSeries B$14MWith 1 other
  33. Apr
    DatabakerSeries B$15MWith 1 other
  34. 2022

    11 rounds

  35. Nov
    Lupeng PharmaceuticalSeries A$35MWith 3 others
  36. Nov
    Primelink BioVenture$14MWith 2 others
  37. Sept
    RealiboxSeries A$14MWith 2 others
  38. Aug
    AoquanSeries B$15MSole investor
  39. Jul
    Apache DolphinSchedulerPre-seed$10MSole investor
  40. Jul
    WangfanxinSeries A$15MWith 2 others
  41. Jun
    YiwiseVentureUndisclosedWith 4 others
  42. Apr
    WorktileSeries C$15MWith 1 other
  43. Apr
    Ke Ning BioSeed$16MSole investor
  44. Feb
    TaoCloudSeries C$866KSole investor
  45. Jan
    Bichen PharmaceuticalSeries B$30MWith 2 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

The team

We hold 1 person at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

Who they invest alongside

The investors most often in the same rounds as Kaitai Capital. A count of rooms they were both in, not a relationship either has claimed.

CDH InvestmentsPrivate equity3rounds togetherFortune Venture CapitalVC firm3rounds togetherGSRVC firm3rounds togetherGSR United CapitalVC firm3rounds togetherHSGVC firm3rounds togetherZhenFundVC firm3rounds togetherBaidu VenturesVC firm2rounds togetherBlueRun VenturesVC firm2rounds togetherCathay CapitalPrivate equity2rounds togetherDeepWork CapitalVC firm2rounds togetherHill House CapitalFamily office2rounds togetherK2VCVC firm2rounds together

Recently backed

The latest companies Kaitai Capital put money into.

Astrocyte Pharmaceuticals$400K · Aug 2026Deep Intelligent Pharma$40M · Mar 2026PaXini Tech$145M · Mar 2026LevinthalDec 2025BridGene Biosciences$28M · Oct 2025Pleryon TherapeuticsAug 2025

Quick answers about Kaitai Capital

What does Kaitai Capital invest in?

Kaitai Capital invests most often at Series A and Venture (54% of the rounds on record), in sectors such as Artificial Intelligence, Biotech and Life Sciences.

How active is Kaitai Capital?

76 investments on record, 8 of them in the last 12 months. The most recent was in Aug 2026.

What has Kaitai Capital invested in recently?

Its most recent investments on record: Astrocyte Pharmaceuticals (Grant, Aug 2026), Deep Intelligent Pharma (Venture, Mar 2026) and PaXini Tech (Series B, Mar 2026).

How big are Kaitai Capital's cheques?

The median round it joins is $14M.

Does Kaitai Capital lead rounds?

Rarely, if at all: none of its 76 investments on record names it as the lead.

Where does Kaitai Capital invest?

Most of the companies it backs are in the United States (83%) and Singapore (17%).

Is Kaitai Capital investing now?

Yes: it is actively investing, with 8 investments in the last 12 months.

Who does Kaitai Capital invest alongside?

Most often CDH Investments (3 rounds together), Fortune Venture Capital (3 rounds together) and GSR (3 rounds together).

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Find similar investorsOpen your CRM

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it